The class of chemicals described as Tsga8 Inhibitors represents a broad range of compounds that, through their primary mechanisms of action, could affect the cellular environment or signaling pathways where Tsga8 might play a role. These compounds do not directly target Tsga8 but could impact processes such as cell division, DNA synthesis, gene expression, protein degradation, and cellular signaling pathways that are crucial for testicular function and spermatogenesis. For instance, paclitaxel and vinblastine disrupt microtubule dynamics, essential for cell division, potentially influencing the environment in which Tsga8 functions. Similarly, compounds like 5-azacytidine and trichostatin A modify the epigenetic landscape, potentially affecting the expression and function of genes like Tsga8 involved in spermatogenesis.
The indirect approach to influencing Tsga8 activity highlights the complexity of cellular processes and the interconnected nature of signaling pathways in spermatogenesis. By targeting critical components of these processes, such as cell growth, division, and differentiation, or by modifying the epigenetic and signaling environment, these chemicals provide insights into the regulatory mechanisms that could indirectly modulate the function of Tsga8. This approach underscores the importance of understanding the broader biological context in which proteins operate, reflecting the intricate interplay between different cellular processes and the potential for chemical interventions to modulate these processes in a way that influences the activity of specific proteins like Tsga8.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $40.00 $73.00 $217.00 $242.00 $724.00 $1196.00 | 39 | |
Inhibits cell division by stabilizing microtubules, potentially affecting spermatogenesis. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $100.00 $230.00 $450.00 $1715.00 $2900.00 | 4 | |
Disrupts microtubule assembly, potentially influencing cell division processes in spermatogenesis. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $65.00 $99.00 $140.00 | 85 | |
Crosslinks DNA, inhibiting DNA synthesis and cell division, possibly affecting Tsga8-related processes. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Induces DNA demethylation, potentially affecting gene expression patterns relevant to Tsga8. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Inhibitor of histone deacetylase, potentially affecting chromatin structure and gene expression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Proteasome inhibitor, potentially affecting protein degradation processes relevant to Tsga8. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR pathway, potentially affecting cell growth and proliferation. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $62.00 $112.00 $214.00 $342.00 | 74 | |
EGFR tyrosine kinase inhibitor, potentially affecting signaling pathways relevant to Tsga8. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
Inhibits multiple kinases, potentially affecting signaling pathways relevant to Tsga8. | ||||||
Zoledronic acid, anhydrous | 118072-93-8 | sc-364663 sc-364663A | 25 mg 100 mg | $90.00 $251.00 | 5 | |
Inhibits farnesyl pyrophosphate synthase, potentially affecting prenylation and cell function. | ||||||